- Published at
- by forbes.com
mixed
mixed
These Stocks Can Offer Higher Returns Compared To Abbott Labs
We believe that there are several stocks in the healthcare sector that are better than Abbott Labs. Abbott’s current market cap-to-operating income ratio of 41x compares with 12x for Emergent Biosolutions, 19x for Vertex Pharmaceuticals, and 22x for Corcept Therapeutics. Does this gap in valuation.